Suchen
LivaNova PLC
LIVNZur Watchlist hinzufügen
71.740USD
+1.650+2.35%
Handelsschluss 05/12, 16:00（ET）Kurse um 15 Minuten verzögert
3.92BMarktkapitalisierung
36.28KGV TTM
mehr Informationen über LivaNova PLC Unternehmen
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
LivaNova PLC Informationen
BörsenkürzelLIVN
Name des UnternehmensLivaNova PLC
IPO-datumOct 19, 2015
CEOMakatsaria (Vladimir A)
Anzahl der mitarbeiter2900
WertpapierartOrdinary Share
GeschäftsjahresendeOct 19
Addresse20 Eastbourne Terrace
StadtLONDON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited Kingdom
PostleitzahlW2 6LG
Telefon442033250662
Websitehttps://www.livanova.com/
BörsenkürzelLIVN
IPO-datumOct 19, 2015
CEOMakatsaria (Vladimir A)
Führungskräfte von LivaNova PLC
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
44.65K
--
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
22.19K
+42.53%
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
--
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
10.97K
+17.36%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
--
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.03K
--
Mr. Michael Damon Hutchinson
Mr. Michael Damon Hutchinson
Senior Vice President, Chief Legal Officer, Company Secretary
Senior Vice President, Chief Legal Officer, Company Secretary
6.80K
--
Ms. Brooke Story
Ms. Brooke Story
Independent Director
Independent Director
6.23K
--
Ahmet Tezel
Ahmet Tezel
Senior Vice President, Chief Innovation Officer
Senior Vice President, Chief Innovation Officer
4.16K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
44.65K
--
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
22.19K
+42.53%
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
--
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
10.97K
+17.36%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
739.57M
53.28%
Rest of World
379.30M
27.33%
Europe
269.18M
19.39%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
11.63%
PRIMECAP Management Company
7.69%
Millennium Management LLC
4.44%
Artisan Partners Limited Partnership
4.21%
AQR Capital Management, LLC
3.92%
Andere
68.10%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
11.63%
PRIMECAP Management Company
7.69%
Millennium Management LLC
4.44%
Artisan Partners Limited Partnership
4.21%
AQR Capital Management, LLC
3.92%
Andere
68.10%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
52.81%
Investment Advisor/Hedge Fund
32.62%
Hedge Fund
13.88%
Research Firm
2.81%
Pension Fund
2.25%
Bank and Trust
1.55%
Individual Investor
0.37%
Sovereign Wealth Fund
0.05%
Family Office
0.04%
Institutionelle Beteiligung
Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
609
60.49M
110.12%
-11.26M
2025Q4
575
58.07M
106.34%
-10.58M
2025Q3
562
56.86M
104.13%
-8.50M
2025Q2
564
56.85M
104.11%
-6.95M
2025Q1
581
56.61M
103.82%
-8.04M
2024Q4
586
56.98M
104.84%
-8.56M
2024Q3
563
55.15M
101.56%
-9.48M
2024Q2
546
57.21M
105.64%
-8.52M
2024Q1
547
58.00M
107.51%
-6.90M
2023Q4
532
56.62M
105.11%
-7.28M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
6.39M
11.68%
+51.59K
+0.81%
Dec 31, 2025
PRIMECAP Management Company
4.22M
7.73%
-219.98K
-4.95%
Dec 31, 2025
Millennium Management LLC
3.48M
6.37%
+514.27K
+17.32%
Dec 31, 2025
Artisan Partners Limited Partnership
2.32M
4.23%
-111.72K
-4.60%
Dec 31, 2025
AQR Capital Management, LLC
2.16M
3.94%
+496.17K
+29.91%
Dec 31, 2025
Wellington Management Company, LLP
2.02M
3.69%
-328.86K
-14.02%
Dec 31, 2025
State Street Investment Management (US)
2.01M
3.68%
-43.95K
-2.14%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
1.79M
3.27%
+66.75K
+3.88%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.46M
2.67%
+12.75K
+0.88%
Dec 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
State Street SPDR S&P Health Care Equipment ETF
1.66%
JPMorgan Active Small Cap Value ETF
1.43%
Invesco NASDAQ Future Gen 200 ETF
0.5%
Simplify Health Care ETF
0.43%
Global X Aging Population ETF
0.42%
JPMorgan Fundamental Data Science Small Core ETF
0.37%
Avantis US Small Cap Equity ETF
0.34%
iShares U.S. Medical Devices ETF
0.34%
WisdomTree US SmallCap Fund
0.33%
Federated Hermes MDT Small Cap Core ETF
0.33%
Mehr Anzeigen
State Street SPDR S&P Health Care Equipment ETF
Anteil1.66%
JPMorgan Active Small Cap Value ETF
Anteil1.43%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.5%
Simplify Health Care ETF
Anteil0.43%
Global X Aging Population ETF
Anteil0.42%
JPMorgan Fundamental Data Science Small Core ETF
Anteil0.37%
Avantis US Small Cap Equity ETF
Anteil0.34%
iShares U.S. Medical Devices ETF
Anteil0.34%
WisdomTree US SmallCap Fund
Anteil0.33%
Federated Hermes MDT Small Cap Core ETF
Anteil0.33%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
